Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$42.76 USD
+0.02 (0.05%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $42.79 +0.03 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Ionis Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -366.29 | -269.72 | -28.60 | -486.77 | 303.26 |
Depreciation/Amortization & Depletion | -0.06 | 34.87 | 42.29 | 67.42 | 47.79 |
Net Change from Assets/Liabilities | -77.26 | 7.57 | -113.82 | -73.56 | -168.71 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 136.09 | -47.09 | 130.92 | 528.80 | 163.38 |
Net Cash From Operating Activities | -307.51 | -274.37 | 30.80 | 35.89 | 345.72 |
Property & Equipment | -23.78 | 238.36 | -11.96 | -35.12 | -30.91 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -186.14 | -496.62 | 212.81 | 315.53 | -4.99 |
Other Investing Activities | -4.21 | -4.38 | -5.95 | -5.93 | -5.38 |
Net Cash from Investing Activities | -214.13 | -262.64 | 194.91 | 274.48 | -41.27 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 49.44 | 6.37 | 101.32 | -38.51 | 141.38 |
Issuance (Repayment) of Debt | 86.90 | -50.69 | 176.95 | 0.00 | -22.11 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 507.74 | -10.98 | -32.33 | -558.10 | -19.24 |
Net Cash from Financing Activities | 644.08 | -55.30 | 245.93 | -596.61 | 100.02 |
Effect of Exchange Rate Changes | 0.35 | -0.42 | -0.11 | 0.62 | 0.00 |
Net Change In Cash & Equivalents | 122.79 | -592.72 | 471.53 | -285.62 | 404.47 |
Cash at Beginning of Period | 276.47 | 869.19 | 397.66 | 683.29 | 278.82 |
Cash at End of Period | 399.27 | 276.47 | 869.19 | 397.66 | 683.29 |
Diluted Net EPS | -2.56 | -1.90 | -0.20 | -3.23 | 2.08 |
Fiscal Year End for Ionis Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -209.07 | -142.80 | -366.29 | -357.02 | -209.61 |
Depreciation/Amortization & Depletion | -4.57 | -1.94 | -0.06 | 1.16 | 1.78 |
Net Change from Assets/Liabilities | -139.55 | -45.52 | -77.26 | -90.25 | -86.57 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 83.37 | 40.32 | 136.09 | 105.74 | 63.05 |
Net Cash From Operating Activities | -269.82 | -149.94 | -307.51 | -340.38 | -231.36 |
Property & Equipment | -10.73 | -4.49 | -23.78 | -24.62 | -22.48 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 164.55 | 81.84 | -186.14 | -159.38 | -231.33 |
Other Investing Activities | -15.26 | -1.24 | -4.21 | -3.41 | -2.31 |
Net Cash from Investing Activities | 138.56 | 76.11 | -214.13 | -187.41 | -256.13 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 26.21 | 23.61 | 49.44 | 8.68 | 4.95 |
Issuance (Repayment) of Debt | -0.08 | -0.04 | 86.90 | 72.76 | 141.11 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 507.74 | 521.92 | 489.57 |
Net Cash from Financing Activities | 26.13 | 23.57 | 644.08 | 603.36 | 635.63 |
Effect of Exchange Rate Changes | -0.14 | -0.11 | 0.35 | 0.02 | 0.17 |
Net Change In Cash & Equivalents | -105.27 | -50.38 | 122.79 | 75.59 | 148.32 |
Cash at Beginning of Period | 399.27 | 399.27 | 276.47 | 276.47 | 276.47 |
Cash at End of Period | 293.99 | 348.89 | 399.27 | 352.06 | 424.79 |
Diluted Net EPS | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |